Selected article for: "acute respiratory distress syndrome and liver heart kidney"

Author: JIANLIN XIANG; JING WEN; XIAOQING YUAN; Shun Xiong; XUE ZHOU; CHANGJIN LIU; XUN MIN
Title: Potential biochemical markers to identify severe cases among COVID-19 patients
  • Document date: 2020_3_23
  • ID: 6rs86u5v_1
    Snippet: To date, the 2019 novel coronavirus pneumonia (COVID-19) is the greatest public health problem in the world. By 10:30 on Mar 19, 2020, the cumulative number of confirmed cases had reached 218,785 globally, including 8,949 deaths. Of the total confirmed COVID-19 patients, about 19.9% were severe cases [1] , which have a mortality rate of about 20%. Severe cases often suffer from underlying diseases such as cardiovascular disease and diabetes that .....
    Document: To date, the 2019 novel coronavirus pneumonia (COVID-19) is the greatest public health problem in the world. By 10:30 on Mar 19, 2020, the cumulative number of confirmed cases had reached 218,785 globally, including 8,949 deaths. Of the total confirmed COVID-19 patients, about 19.9% were severe cases [1] , which have a mortality rate of about 20%. Severe cases often suffer from underlying diseases such as cardiovascular disease and diabetes that can accelerate the progression of 2019 novel coronavirus (SARS-CoV-2) infection [2, 3] . Furthermore, acute respiratory distress syndrome could lead to death in some severe COVID-19 patients, and this is often accompanied by heart failure, liver failure, and kidney failure [2, 4] . Therefore, early, simple and effective diagnosis of severe COVID-19 pneumonia is of great significance in reducing mortality and shortening the hospitalization period.

    Search related documents:
    Co phrase search for related documents